Loading organizations...

Paragraf is a technology company.
Paragraf develops and mass-produces graphene-based electronic devices, leveraging standard semiconductor processes to bring advanced materials into real-world applications. The company offers a suite of products, including Graphene Molecular Sensors (GMS) for diverse sensing needs, Graphene Hall Sensors (GHS) for magnetic field detection, and Custom 2D Foundry Services for next-generation solid-state devices. Their technical approach emphasizes direct graphene deposition, enabling superior sensitivity and noise tolerance.
Founded in 2015, Paragraf was established with the insight that graphene, despite its transformative potential, required a focused and robust manufacturing approach to overcome the complexities of its application in electronics. The company's technical foundation is rooted in deep expertise in physics, materials science, and advanced deposition techniques, translating the theoretical advantages of graphene into practical, industrial-ready devices.
Paragraf’s products find utility across multiple high-growth sectors, including molecular sensing for healthcare and environmental monitoring, cryogenics, quantum computing, and automotive for improved electric vehicle safety. The company envisions a future where its graphene technologies contribute to healthier populations through faster diagnostics, more efficient urban environments via enhanced energy solutions, and a healthier planet by reducing the energy footprint of global compute infrastructure.
Paragraf has raised $140.0M across 5 funding rounds.
Paragraf has raised $140.0M in total across 5 funding rounds.
Paragraf is a UK-based semiconductor company that mass-produces graphene-based electronic devices using standard processes, offering products like Graphene Hall Sensors (GHS) for magnetic field detection, Graphene Field-Effect Transistors (GFETs) for molecule sensing, and custom 2D foundry services.[1][3][4][6] It serves industries including automotive (EV safety), healthcare (biosensing), quantum computing, cryogenics, precision farming, and environmental sensing, solving problems like low sensitivity, high noise, and energy inefficiency in traditional sensors.[1][3][6] Founded in 2017 as a University of Cambridge spin-out (formerly 2D Technologies), Paragraf has raised $85.38M–$140M across rounds, achieved prototypes by 2018, expanded with a Series B in 2022, acquired Cardea Bio in 2023, and operates advanced foundries in the UK and US, signaling strong growth momentum.[1][2][3][4]
Paragraf emerged as a 2017 spin-out from the University of Cambridge's Centre for Gallium Nitride group, led by Professor Sir Colin Humphreys in the Department of Materials Science, to commercialize graphene-based electronics.[2][3][4] Initially known as 2D Technologies, it secured £2.9M in seed funding that year, transferring lab technology into a commercial entity based in Somersham, UK.[1][4] Key executive Andrew Cowell, a serial entrepreneur experienced in academic spin-outs and exits like Orthomimetics and CamGaN, has driven leadership.[4] Early milestones included opening development labs and delivering first GHS prototypes in 2018, followed by a £16.2M Series A in 2019, Series B (£48.5M) in 2022 with US expansion, a second UK site, and the 2023 Cardea Bio acquisition to boost biosensors.[1][2][4]
Paragraf stands out in the graphene semiconductor space through these key advantages:
Paragraf rides the 2D materials revolution in semiconductors, leveraging graphene's superior electron mobility and properties to address silicon's scaling limits amid rising demands for efficient sensing in AI, EVs, quantum tech, and biotech.[3][4][6] Timing aligns with global pushes for clean energy (EV adoption, precision ag), health equity (rapid diagnostics post-COVID), and quantum scaling, where its cryo-sensors combat decoherence—critical as quantum investments surge.[1][6] Market tailwinds include semiconductor shortages, net-zero goals, and 2D tech hype, with Paragraf influencing the ecosystem via Cambridge heritage, partnerships (e.g., Taiwan awards, Tachmed), and foundry services that democratize graphene integration, potentially slashing compute energy footprints and enabling "healthy planet" outcomes like cleaner cities and sustainable farming.[2][4][6]
Paragraf is poised to scale its foundry output and biosensor portfolio, targeting explosive growth in EVs, quantum, and point-of-care health via acquisitions like Cardea Bio and high-volume deals.[1][4] Trends like AI-driven sensing, quantum commercialization, and green tech mandates will amplify demand for its efficient 2D devices, potentially capturing share in a $500B+ sensor market. Influence may evolve from niche innovator to semiconductor staple, driving the 2D shift that transforms performance across industries—echoing its Cambridge roots in unlocking graphene's full potential for global challenges.[3][6]
Paragraf has raised $140.0M in total across 5 funding rounds.
Paragraf's investors include Amadeus Capital Partners, Digitalis Ventures, Parkwalk Advisors, Bernhard Niesner, Johann "Hansi" Hansmann, Judith Hartley MBE, Draper Esprit, In-Q-Tel, IQ Capital, Cambridge Enterprise, Partners Investment, Hermann Hauser.
Paragraf has raised $140.0M across 5 funding rounds. Most recently, it raised $55.0M Series C in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 25, 2025 | $55.0M Series C | ||
| Feb 1, 2022 | $60.0M Series B | Amadeus Capital Partners, Digitalis Ventures, Parkwalk Advisors, Bernhard Niesner, Johann "Hansi" Hansmann, Amadeus Capital Partners, Judith Hartley MBE, Draper Esprit, In-Q-Tel, IQ Capital | |
| Dec 1, 2019 | $5.0M Series A | Parkwalk Advisors | Digitalis Ventures, Amadeus Capital Partners, Cambridge Enterprise, Draper Esprit, IQ Capital, Partners Investment |
| Jul 1, 2019 | $16.0M Series A | Parkwalk Advisors | Amadeus Capital Partners, Digitalis Ventures, Bernhard Niesner, Johann "Hansi" Hansmann, Amadeus Capital Partners, Cambridge Enterprise, IQ Capital |
| Apr 1, 2018 | $4.0M Seed | Cambridge Enterprise | Amadeus Capital Partners, Digitalis Ventures, Parkwalk Advisors, Bernhard Niesner, Johann "Hansi" Hansmann, Hermann Hauser, IQ Capital |